Aminophylline
A mixture comprising of theophylline and ethylenediamine in a 2:1 ratio. — ChEBI
Quick answers about Aminophylline
Identity · formula · massWhat is Aminophylline, CAS 317-34-0?
Aminophylline is the substance linked to CAS 317-34-0 in ChEBI entry CHEBI:2659. The reported formula is C2H8N2.2C7H8N4O2. Confirm the structural identifiers when distinguishing salts, hydrates, isomers or isotopically labelled materials.
Source ↗What is the molar mass of Aminophylline?
The ChEBI-reported molar mass is 420.434 g/mol for formula C2H8N2.2C7H8N4O2. Its source-reported monoisotopic mass is 420.1982 Da; that uses a specific isotope composition and is a different quantity.
Source ↗Which PubChem properties are available for Aminophylline?
CID 9433 is connected to this record by an exact InChIKey match. PubChem reports exact mass 420.19819929 Da. Values and source conventions are shown separately in the property tables below.
Source ↗Identity & molecular properties
Source-linked values| CAS number | 317-34-0 | ChEBI ↗ |
| Chemical formula | C2H8N2·2C7H8N4O2 | ChEBI ↗ |
| Molar mass | 420.434 g/mol | ChEBI ↗ |
| Monoisotopic mass | 420.1982 Da | ChEBI ↗ |
| Formal charge | 0 | ChEBI ↗ |
| ChEBI identifier | CHEBI:2659 | ChEBI ↗ |
PubChem molecular properties
PubChem| Molar mass | 420.43 g/mol | PubChem ↗ |
| Exact mass | 420.19819929 Da | PubChem ↗ |
PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.
Names & structural identifiers
Copy any identifieraminophylline1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione - ethane-1,2-diamine (2:1)FQPFAHBPWDRTLU-UHFFFAOYSA-NCn1c(=O)c2ncnc2n(C)c1=O.Cn1c(=O)c2ncnc2n(C)c1=O.NCCNInChI=1S/2C7H8N4O2.C2H8N2/c2*1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2-4/h2*3H,1-2H3,(H,8,9);1-4H2Names & synonyms
Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.
Classification & relationships
ChEBI ontologyRoles recorded in ChEBI
Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.
Safety documents & references
1 indexed referencesFind a product-specific SDS
Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.
Safety classification · Japan
NITE / Japanese governmentAminophylline · 23A5139
| Endpoint | Reported classification |
|---|---|
| Acute toxicity (Oral) | Category 4 |
| Skin sensitization | Category 1 |
| Reproductive toxicity | Category 2, Additional category: Effects on or via lactation |
| Specific target organ toxicity - Single exposure | Category 1 (cardiovascular system, nervous system, digestive system) |
| Specific target organ toxicity - Repeated exposure | Category 1 (cardiovascular system, nervous system, digestive system) |
Selected source-reported endpoints. Other endpoints, rationales and conditions remain in the original classification. Missing or unlisted information does not mean non-hazardous. This is not a global classification or transport decision.
Read the original NITE classificationMass ↔ amount of substance
Calculated from sourced massUses 420.434 g/mol from ChEBI; basis: the substance and formula represented in this record. No purity or concentration correction is applied.
Elemental composition
Theoretical mass fractionsNCOHCalculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.
Research & patent references
Selected source associationsSources & record history
Checked 27 Sep 2026Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0
PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.